Abstract Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a
predilection for Asian and South American populations. Epstein–Barr virus (EBV) infection in …

Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignancy of putative NK-
cell origin, with a minority deriving from the T-cell lineage. Pathologically, the malignancy …

Background The clinical outcome of extranodal natural killer T-cell lymphoma (ENKTL) has
improved substantially as a result of new treatment strategies with non-anthracycline-based …

Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein–Barr virus (EBV)-related non-
Hodgkin lymphomas common in Asia and Latin America but rare elsewhere. Its …

Extranodal natural killer/T-cell lymphoma, nasal type (ENKL) is a subtype of mature T-and
natural killer cell lymphomas characterized by its association with Epstein-Barr virus and …

Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) is an aggressive malignancy
associated with Epstein-Barr virus infection, with a geographic and racial predilection for …

The optimal combination and sequence of radiotherapy (RT) and chemotherapy (CT) for
extranodal nasal-type natural killer/T-cell lymphoma (NKTCL) are not well-defined. The aim …

Purpose To elucidate the management and outcomes of patients with extranodal natural
killer/T-cell lymphoma, nasal type (ENKL), who were diagnosed between 2000 and 2013 in …

The present study investigated the survival benefit of non–anthracycline (ANT)-based vs
ANT-based regimens in a large-scale, real-world cohort of patients with extranodal natural …

NK/T-cell lymphomas are extranodal EBV-related malignancies, mostly of NK-cell and
occasionally of T-cell lineage. They are divided into nasal, non-nasal, and disseminated …